Aptevo Therapeutics Share Price Today
(NASDAQ: APVO)

Name: Aptevo Therapeutics Share Price Today (NASDAQ: APVO) - Aptevo Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Aptevo Therapeutics share price is $2.77 & ₹240.90 as on 6 Mar 2025, 2.30 'hrs' IST

$2.77

▲

-0.18

(-6.1%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aptevo Therapeutics share price in Dollar and Rupees. Guide to invest in Aptevo Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aptevo Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aptevo Therapeutics share price movements

Today's Low: $2.76
Today's High: $3.05
$2.77
0.36%
Downside
Day's Volatility :9.36%
Upside
9.03%
52 Weeks Low: $2.77
52 Weeks High: $399.60
$2.77
0.0%
Downside
52 Weeks Volatility :99.31%
Upside
99.31%

Aptevo Therapeutics (APVO) Returns

Period	Aptevo Therapeutics Inc	Index (Russel 2000)
3 Months	-70.44%	0.0%
6 Months	-76.47%	0.0%
1 Year	-98.75%	0.0%
3 Years	-99.96%	-11.6%

Aptevo Therapeutics (APVO) Key Statistics

in dollars & INR

Previous Close	$2.95
Open	$2.98
Today's High	$3.045
Today's Low	$2.76
Market Capitalization	$5.6M
Today's Volume	$2.9K
52 Week High	$399.6
52 Week Low	$2.76
Revenue TTM	$0.0
EBITDA	$-24.3M
Earnings Per Share (EPS)	$-72.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-284.28%

How to invest in Aptevo Therapeutics Stock (APVO) from India?

It is very easy for Indian residents to invest directly in Aptevo Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptevo Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptevo Therapeutics or APVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptevo Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptevo Therapeutics shares which would translate to 0.314 fractional shares of Aptevo Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptevo Therapeutics, in just a few clicks!

Returns in Aptevo Therapeutics (APVO) for Indian investors in Rupees

The Aptevo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Aptevo Therapeutics investment value today

Current value as on today

₹6,133

Returns

₹93,867

(-93.87%)

Returns from Aptevo Therapeutics Stock

₹98,830 (-98.83%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aptevo Therapeutics (APVO)

-53%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aptevo Therapeutics Stock from India on INDmoney has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aptevo Therapeutics

Virtu Financial LLC
1.48%
HRT FINANCIAL LLC
0.85%
JPMorgan Chase & Co
0.31%
Diadema Partners LP
0.28%
Morgan Stanley - Brokerage Accounts
0.27%
Tower Research Capital LLC
0.07%

Analyst Recommendation on Aptevo Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Aptevo Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptevo Therapeutics Stock (APVO)

What analysts predicted

Upside of 658.12%

Target:

$21.00

Current:

$2.77

Insights on Aptevo Therapeutics Stock (Ticker Symbol: APVO)

Price Movement
In the last 3 months, APVO stock has moved down by -70.4%
APVO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 160.9%
APVO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.7%

Aptevo Therapeutics Technicals Summary

Sell

Neutral

Buy

Aptevo Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aptevo Therapeutics (APVO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptevo Therapeutics Inc	-32.18%	-76.47%	-98.75%	-99.96%	-99.96%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptevo Therapeutics Inc	NA	NA	0.0	-15.84	-2.84	-0.76	NA	3.26
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptevo Therapeutics Inc	Buy	$5.6M	-99.96%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Aptevo Therapeutics

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Organization	Aptevo Therapeutics
Employees	37
CEO	Mr. Marvin L. White
Industry	Health Technology

Management People of Aptevo Therapeutics

Name	Title
Mr. Marvin L. White	President, CEO & Director
Mr. Jeffrey G. Lamothe CA	Executive VP & COO
Ms. SoYoung Kwon J.D., LL.M.	Senior VP, General Counsel, Business Development & Corporate Affairs
Dr. Dirk Huebner M.D.	Chief Medical Officer

Important FAQs about investing in APVO Stock from India :

What is Aptevo Therapeutics share price today?

Aptevo Therapeutics share price today stands at $2.77, Open: $2.98 ; Previous Close: $2.95 ; High: $3.05 ; Low: $2.76 ; 52 Week High: $399.60 ; 52 Week Low: $2.77.

The stock opens at $2.98, after a previous close of $2.95. The stock reached a daily high of $3.05 and a low of $2.76, with a 52-week high of $399.60 and a 52-week low of $2.77.

Can Indians buy Aptevo Therapeutics shares?

Yes, Indians can invest in the Aptevo Therapeutics (APVO) from India.

With INDmoney, you can buy Aptevo Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptevo Therapeutics at zero transaction cost.

How can I buy Aptevo Therapeutics shares from India?

It is very easy to buy Aptevo Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptevo Therapeutics (APVO) be purchased?

Yes, you can buy fractional shares of Aptevo Therapeutics with INDmoney app.

What are the documents required to start investing in Aptevo Therapeutics stocks?

To start investing in Aptevo Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.